Evidence map›Paper›PMID 38632316›Full record

ArticleLeukemia2024

Mutations in the splicing factor SF3B1 are linked to frequent emergence of HLA-DR

Susann Winter, Marie Schneider, Uta Oelschlaegel, Giulia Maggioni, Elena Riva, Marco Gabriele Raddi, Sara Bencini, Benedetta Peruzzi, Desmond Choy, Rita Antunes Dos Reis and 13 more

Open access · hybridAbstract readLetter
In one paragraph

Article in Leukemia, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 8 institutions in 3 countries.

Susann Winter *Department of Internal Medicine I, University Hospital Carl Gustav Carus, Faculty of Medicine Carl Gustav Carus, TU Dresden, Dresden, Germany.ORCID 0000-0002-4228-4537
Marie Schneider *Department of Hematology, Cellular Therapy, Hemostaseology and Infectious Disease, University of Leipzig Medical Center, Leipzig, Germany.ORCID 0000-0001-9022-5470
Uta OelschlaegelDepartment of Internal Medicine I, University Hospital Carl Gustav Carus, Faculty of Medicine Carl Gustav Carus, TU Dresden, Dresden, Germany.ORCID 0000-0002-2287-437X
Giulia MaggioniComprehensive Cancer Centre, School of Cancer and Pharmaceutical Sciences, King's College London, London, UK.
Elena RivaComprehensive Cancer Centre, School of Cancer and Pharmaceutical Sciences, King's College London, London, UK.ORCID 0000-0002-0701-3889
Marco Gabriele RaddiMDS Unit, Hematology, AOU Careggi - Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Sara BenciniFlow Cytometry Diagnostic Center and Immunotherapy (CDCI), AOU Careggi, Florence, Italy.
Benedetta PeruzziFlow Cytometry Diagnostic Center and Immunotherapy (CDCI), AOU Careggi, Florence, Italy.
Desmond ChoyComprehensive Cancer Centre, School of Cancer and Pharmaceutical Sciences, King's College London, London, UK.
Rita Antunes Dos ReisComprehensive Cancer Centre, School of Cancer and Pharmaceutical Sciences, King's College London, London, UK.ORCID 0000-0002-0182-6694
Esther GüseLaboratory of Systems Tumor Immunology, Friedrich-Alexander-Universität Erlangen-Nürnberg, and Universitätsklinikum Erlangen, Erlangen, Germany.
Christopher LischerLaboratory of Systems Tumor Immunology, Friedrich-Alexander-Universität Erlangen-Nürnberg, and Universitätsklinikum Erlangen, Erlangen, Germany.ORCID 0000-0001-8876-7756
Julio VeraLaboratory of Systems Tumor Immunology, Friedrich-Alexander-Universität Erlangen-Nürnberg, and Universitätsklinikum Erlangen, Erlangen, Germany.
Jessica A TimmsComprehensive Cancer Centre, School of Cancer and Pharmaceutical Sciences, King's College London, London, UK.
Nicolas SompairacComprehensive Cancer Centre, School of Cancer and Pharmaceutical Sciences, King's College London, London, UK.ORCID 0000-0001-8759-2077
Katja SockelDepartment of Internal Medicine I, University Hospital Carl Gustav Carus, Faculty of Medicine Carl Gustav Carus, TU Dresden, Dresden, Germany.ORCID 0000-0003-1732-7299
Antonella PoloniDepartment of Clinical and Molecular Sciences, Università Politecnica delle Marche, Ancona, Italy.
Antje TungerInstitute of Immunology, Faculty of Medicine Carl Gustav Carus, TU Dresden, Dresden, Germany.
Matteo Giovanni Della PortaIRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.ORCID 0000-0002-6915-5970
Valeria SantiniMDS Unit, Hematology, AOU Careggi - Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.ORCID 0000-0002-5439-2172
Marc SchmitzInstitute of Immunology, Faculty of Medicine Carl Gustav Carus, TU Dresden, Dresden, Germany.
Uwe Platzbecker *Department of Hematology, Cellular Therapy, Hemostaseology and Infectious Disease, University of Leipzig Medical Center, Leipzig, Germany.ORCID 0000-0003-1863-3239
Shahram Kordasti *Comprehensive Cancer Centre, School of Cancer and Pharmaceutical Sciences, King's College London, London, UK. shahram.kordasti@kcl.ac.uk.ORCID 0000-0002-0347-4207
King's College London · GBFriedrich-Alexander-Universität Erlangen-Nürnberg · DEUniversity Hospital Carl Gustav Carus · DEGerman Cancer Research Center · DEMarche Polytechnic University · ITUniversity of Florence · ITHelmholtz-Zentrum Dresden-Rossendorf · DEHumanitas University · IT

Funding

Associazione Italiana per la Ricerca sul Cancro (Italian Association for Cancer Research) #22053Associazione Italiana per la Ricerca sul Cancro (Italian Association for Cancer Research) #26537EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020) EuroMDS project #20180424
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

HLA-DR AntigensMonocytesMutationMyelodysplastic SyndromesPhosphoproteinsRNA Splicing FactorsHumansHLA-DR AntigensPhosphoproteinsRNA Splicing FactorsSF3B1 protein, human

Identifiers

PMID38632316
PMCPMC11147767
OpenAlexW4394874479

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.